CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 82 filers reported holding CATALYST BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $87,000 | -8.4% | 20,143 | +24.0% | 0.06% | -11.6% |
| Q2 2020 | $95,000 | -11.2% | 16,238 | -33.5% | 0.07% | -27.4% |
| Q1 2020 | $107,000 | -35.5% | 24,429 | 0.0% | 0.10% | -35.4% |
| Q4 2019 | $166,000 | -1.2% | 24,429 | -28.9% | 0.15% | -10.9% |
| Q3 2019 | $168,000 | -27.3% | 34,344 | +9.8% | 0.16% | -21.4% |
| Q2 2019 | $231,000 | +5.5% | 31,284 | +15.9% | 0.21% | -8.7% |
| Q1 2019 | $219,000 | +9.0% | 26,994 | +5.9% | 0.23% | +8.5% |
| Q4 2018 | $201,000 | – | 25,494 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,076,376 | $13,321,000 | 6.97% |
| 22NW, LP | 1,429,242 | $6,189,000 | 1.66% |
| Ghost Tree Capital, LLC | 1,000,000 | $4,330,000 | 1.19% |
| ACUTA CAPITAL PARTNERS, LLC | 685,000 | $2,966,000 | 1.18% |
| Sio Capital Management, LLC | 623,892 | $2,701,000 | 0.67% |
| Parkman Healthcare Partners LLC | 393,449 | $1,704,000 | 0.37% |
| Nantahala Capital Management | 2,531,360 | $10,961,000 | 0.31% |
| AlphaCentric Advisors LLC | 182,500 | $790,000 | 0.22% |
| Ikarian Capital, LLC | 581,200 | $2,518,000 | 0.20% |
| Tibra Equities Europe Ltd | 79,200 | $343,000 | 0.11% |